Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

472
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
472
Behavior Therapy01:22

Behavior Therapy

758
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
758
Drug Therapy01:28

Drug Therapy

312
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
312
Cognitive Therapy01:25

Cognitive Therapy

1.3K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.3K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of heterozygous beta thalassemia on HbA1c levels in individuals without diabetes mellitus: A cross sectional study.

Clinica chimica acta; international journal of clinical chemistry·2019
Same author

Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells).

Hematology (Amsterdam, Netherlands)·2016
Same author

The Economic Burden of Treating Thalassemia In Greece.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Co-Existence of Hereditary Pyrimidine 5'-Nucleotidase Deficiency and Heterozygous α-Thalassemia: A Case Presentation.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2014
Same author

Mediterranean fever gene mutations in Greek patients with Behcet's disease.

The West Indian medical journal·2012
Same author

High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2012

Related Experiment Video

Updated: Feb 16, 2026

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain
04:24

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain

Published on: June 6, 2025

1.3K

Hydroxyurea therapy in thalassemia

D Loukopoulos1, E Voskaridou, A Stamoulakatou

  • 1First Department of Medicine, University of Athens, Laikon Hospital, Greece. dloukop@atlas.uoa.gr

Annals of the New York Academy of Sciences
|July 21, 1998
PubMed
Summary

Hydroxyurea treatment significantly increases fetal hemoglobin in thalassemia patients, improving energy levels and reducing painful episodes in sickle cell/beta-thalassemia. This suggests a potential benefit for managing these blood disorders.

More Related Videos

Author Spotlight: Treating Frozen Shoulder with Small Needle Knife Therapy
05:52

Author Spotlight: Treating Frozen Shoulder with Small Needle Knife Therapy

Published on: November 17, 2023

2.4K
Studying Cavitation Enhanced Therapy
07:36

Studying Cavitation Enhanced Therapy

Published on: April 9, 2021

5.9K

Related Experiment Videos

Last Updated: Feb 16, 2026

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain
04:24

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain

Published on: June 6, 2025

1.3K
Author Spotlight: Treating Frozen Shoulder with Small Needle Knife Therapy
05:52

Author Spotlight: Treating Frozen Shoulder with Small Needle Knife Therapy

Published on: November 17, 2023

2.4K
Studying Cavitation Enhanced Therapy
07:36

Studying Cavitation Enhanced Therapy

Published on: April 9, 2021

5.9K

Area of Science:

  • Hematology
  • Pharmacology

Background:

  • The clinical effectiveness of Hydroxyurea in managing thalassemia remains debated.
  • Thalassemia intermedia and sickle cell/beta-thalassemia are chronic blood disorders requiring effective treatment strategies.

Purpose of the Study:

  • To evaluate the clinical effectiveness of Hydroxyurea in patients with thalassemia intermedia and sickle cell/beta-thalassemia.
  • To assess the impact of Hydroxyurea, alone and in combination with erythropoietin, on hematological parameters and patient-reported outcomes.

Main Methods:

  • Retrospective analysis of patients with thalassemia intermedia and sickle cell/beta-thalassemia treated with varying Hydroxyurea dosages.
  • A third group received Hydroxyurea combined with recombinant human erythropoietin.
  • Observation over several months to assess changes in hemoglobin levels, fetal hemoglobin, erythrocyte indices, and clinical symptoms.

Main Results:

  • Hydroxyurea treatment led to a significant increase in fetal hemoglobin (HbF) without altering total hemoglobin levels.
  • Erythrocyte volume and hemoglobin content increased, while MCHC remained unchanged.
  • Patients reported subjective improvements in energy levels and well-being; sickle cell/beta-thalassemia patients experienced fewer crises.

Conclusions:

  • Hydroxyurea effectively increases fetal hemoglobin and may improve red blood cell quality in thalassemia patients.
  • The observed clinical benefits, including increased energy and reduced crises, are likely linked to reduced ineffective erythropoiesis.
  • Hydroxyurea shows promise as a therapeutic agent for thalassemia intermedia and sickle cell/beta-thalassemia.